rs397515956
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 4P and 2B. PM1PM5BP4_Moderate
The NM_000256.3(MYBPC3):c.2197C>T(p.Arg733Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000855 in 1,613,858 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R733H) has been classified as Pathogenic.
Frequency
Consequence
NM_000256.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYBPC3 | NM_000256.3 | c.2197C>T | p.Arg733Cys | missense_variant | 23/35 | ENST00000545968.6 | NP_000247.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYBPC3 | ENST00000545968.6 | c.2197C>T | p.Arg733Cys | missense_variant | 23/35 | 5 | NM_000256.3 | ENSP00000442795 | P4 | |
MYBPC3 | ENST00000399249.6 | c.2197C>T | p.Arg733Cys | missense_variant | 22/34 | 5 | ENSP00000382193 | A2 | ||
MYBPC3 | ENST00000544791.1 | c.2197C>T | p.Arg733Cys | missense_variant, NMD_transcript_variant | 23/27 | 5 | ENSP00000444259 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152134Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000603 AC: 15AN: 248658Hom.: 0 AF XY: 0.0000519 AC XY: 7AN XY: 134976
GnomAD4 exome AF: 0.0000876 AC: 128AN: 1461606Hom.: 1 Cov.: 31 AF XY: 0.0000839 AC XY: 61AN XY: 727082
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152252Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74440
ClinVar
Submissions by phenotype
Hypertrophic cardiomyopathy Uncertain:4
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 19, 2022 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 733 of the MYBPC3 protein (p.Arg733Cys). This variant is present in population databases (rs397515956, gnomAD 0.02%). This missense change has been observed in individual(s) with hypertrophic cardiomyopathy (PMID: 15519027, 27532257). ClinVar contains an entry for this variant (Variation ID: 42607). An algorithm developed specifically for the MYBPC3 gene suggests that this missense change is likely to be tolerated (PMID: 21310275). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | research | Agnes Ginges Centre for Molecular Cardiology, Centenary Institute | Mar 22, 2017 | This MYBPC3 Arg733Cys variant has been reported in 1 HCM proband by Van Driest et al. (2004) in their cohort of 389 unrelated HCM probands, where only the MYBPC3 gene was screened and 2 HCM probands by Walsh et al. (2017). The variant has also been identified in 1 control (Kapplinger JD, et al., 2014) and is present in the Exome Aggregation Consortium dataset (http://exac.broadinstitute.org/) at an allele frequency >0.00008, which is higher then expected for HCM. We have identified this variant in 1 HCM proband who experienced a resuscitated cardiac arrest. This proband also carries an additional known pathogenic splice variant in MYBPC3 (c.1928-2A>G). Computational analyses (SIFT, MutationTaster) support a potentially deleterious effect. However, a tool specifically designed to predict the effects of missense variants in HCM genes (Jordan DM, et al., 2011), predicts this variant to have a "benign" affect. Based on the elevated allele frequency in the general population, observation of the variant in 1 control and a total of 4 HCM probands, we classify MYBPC3 Arg733Cys as variant of "uncertain significance". - |
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 05, 2019 | The p.Arg733Cys variant in MYBPC3 has been reported in at least 2 individuals with HCM (Van Driest 2004, LMM data). This variant has been identified in 9/126440 of European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org/; dbSNP rs397515956). This variant has been reported in ClinVar (Variant ID: 42607). Clinvar: VUS (5 submitters). Arginine (Arg) at position 733 is not conserved in mammals, or evolutionarily distant species and the change to cystine (Cys) was predicted to be benign using a computational tool clinically validated by our laboratory. This tool's benign prediction is estimated to be correct 89% of the time (Jordan 2011). In addition, this amino acid change is present in the rhesus macaque. In summary, the clinical significance of the p.Arg733Cys variant is uncertain. - |
Uncertain significance, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Sep 23, 2024 | This missense variant replaces arginine with cysteine at codon 733 of the MYBPC3 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). Splice site prediction tools suggest that this variant may not impact RNA splicing. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in a few individuals affected with hypertrophic cardiomyopathy (PMID: 15519027, 27532257, 33782553) and in a healthy control individual (PMID: 24510615). This variant has been identified in 17/280042 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Hypertrophic cardiomyopathy 4 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Uncertain significance, criteria provided, single submitter | curation | SIB Swiss Institute of Bioinformatics | May 31, 2018 | This variant is interpreted as a Uncertain Significance - Insufficient Evidence, for Cardiomyopathy, familial hypertrophic, 4, in Autosomal Dominant manner. The following ACMG Tag(s) were applied: PM2-Supporting =>PM2 downgraded in strength to Supporting. - |
not specified Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Stanford Center for Inherited Cardiovascular Disease, Stanford University | Feb 25, 2015 | Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. MYBPC3 p.Arg733Cys Given weak case data and the fact that few pathogenic variants in MYBPC3 are missense, we consider it a variant of uncertain significance. The variant has been seen in at least one case of HCM (not including this patient's family). There is no segregation data available. Dr. Ackerman's group reported the variant in one patient with HCM from their 389 patient Mayo cohort (van Driest et al 2004). No ancestry or segregation data was reported. They only analyzed MYBPC3 in that study. The arginine at codon 733 is only partially conserved across species, with a histidine at that position in some non-mammals. This is a non-conservative amino acid substitution (Grantham score 180). I could find only one nearby missense variant (p.Arg726Cys (HGMD, Seidmans' database)). Of note, the majority of disease-causing variants in MYBPC3 are splice, nonsense, or frameshift variants. The splicing algorithms that mutationtaster uses did not predict a significant effect on splicing. - |
Hypertrophic cardiomyopathy 4;C3715165:Left ventricular noncompaction 10 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 01, 2021 | - - |
Cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Apr 25, 2023 | This missense variant replaces arginine with cysteine at codon 733 of the MYBPC3 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in individuals affected with hypertrophic cardiomyopathy (PMID: 15519027, 27532257, 33782553). This variant has been identified in 17/280042 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 07, 2023 | Reported in individuals referred for HCM genetic testing at GeneDx and in the published literature (PMID: 15519027, 27532257) as well as in one control individual (PMID: 24510615); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 21415409, 27532257, 24510615, 34426522, 21310275, 30681346, 30937429, 26659599, 31983221, 15519027) - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2023 | The p.R733C variant (also known as c.2197C>T), located in coding exon 23 of the MYBPC3 gene, results from a C to T substitution at nucleotide position 2197. The arginine at codon 733 is replaced by cysteine, an amino acid with highly dissimilar properties. This alteration has been reported in association with hypertrophic cardiomyopathy (HCM), although clinical details were limited (Van Driest SL et al. J. Am. Coll. Cardiol., 2004 Nov;44:1903-10; Walsh R et al. Genet. Med., 2017 Feb;19:192-203). This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at